| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $51.3M | +30.5% |
| Cost of Revenue | $8.3M | +33.2% |
| Gross Profit | $43.0M | +30.0% |
| R&D Expense | $11.1M | -4.3% |
| SG&A Expense | $91.3M | +41.6% |
| Operating Income | -$59.5M | -38.0% |
| Pre-tax Income | -$59.9M | -45.9% |
| Income Tax | $55K | -62.6% |
| Net Income | -$60.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.9M | +17.0% |
| Accounts Receivable | $9.3M | +22.7% |
| Inventory | $12.1M | +10.2% |
| Current Assets | $129.8M | +15.8% |
| Total Assets | $133.4M | +15.8% |
| Current Liabilities | $10.8M | +36.9% |
| Long-term Debt | $49.3M | +68.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.1M | -0.3% |
| Capital Expenditures | $1.4M | +130.3% |
| Investing Cash Flow | -$1.4M | -130.3% |
| Financing Cash Flow | $55.9M | +132.9% |
| Free Cash Flow | -$40.5M | -2.3% |
| -45.5% |
| EPS (Basic) | -$2.65 | -33.2% |
| EPS (Diluted) | -$2.65 | -33.2% |
| Total Liabilities |
| $62.4M |
| +58.7% |
| Stockholders' Equity | $71.1M | -6.4% |